Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bloomberg: Stablecoin Bill Gains Bipartisan Support in the U.S., Poised for Swift Revival in the Senate

Bloomberg: Stablecoin Bill Gains Bipartisan Support in the U.S., Poised for Swift Revival in the Senate

星球日报星球日报2025/05/14 01:24
Show original

Odaily Planet Daily News: According to Bloomberg, U.S. bipartisan senators are accelerating the push for the "rebirth" of stablecoin legislation supported by the cryptocurrency industry. Previously, the legislation was stalled due to controversies surrounding Trump's cryptocurrency investment portfolio. The primary Republican sponsor of the legislation, Tennessee Senator Bill Hagerty, stated at the Capitol that both parties are continuously advancing, hoping for Democratic approval before the May 26 holiday recess, as the Senate will focus on the Republican fiscal plan. He candidly remarked, "It's time to see if reason can prevail."


Progressive Democrats like Elizabeth Warren are pushing to ban officials like Trump from profiting from cryptocurrency investments during their terms, which has been rejected by Republicans. Chuck Schumer and others have complained about the lack of public text for the bipartisan compromise proposal. The primary Democratic sponsor, Maryland Senator Angela Alsobrooks, stated that senators are working hard, and she, along with four other Democrats, has voted in favor in the Banking Committee. In the Senate, most legislation requires 60 votes, making Democratic support crucial.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Trump promotes the "manufacturing card" again for midterm elections: Audi to invest $4 billion in a U.S. plant, plans annual production of 200,000 SUVs

Audi plans to invest 4 billion dollars to build a factory in the United States, with an annual production capacity of 200,000 SUVs, creating 4,500 jobs. The German labor union criticized the CEO's supportive attitude as "puzzling," and the final decision will be made by the Volkswagen supervisory board.

智通财经•2026/10/26 03:11
Trump promotes the "manufacturing card" again for midterm elections: Audi to invest $4 billion in a U.S. plant, plans annual production of 200,000 SUVs